Thompson Designs, Inc., the predecessor corporation to BioPharmX, was founded in 2010.
BioPharmX refers to BioPharmX Corporation, which was incorporated in Delaware on April 24, 2014.
BioPharmX is located at 1505 Adams Drive, Suite D, Menlo Park, California 94025.
BioPharmX went public by a reverse merger with a shell company in January of 2014.
Our stock is traded on the NYSE MKT under the symbol BPMX.
BioPharmX’s fiscal year ends January 31.
Information on BioPharmX’s Management Team can be found here.
If you hold BioPharmX stock in your name (versus through a stockbroker) please contact BioPharmX’s transfer agent: Computershare
60 S. Market Street, Suite 800
San Jose, CA 95133
You can read or download a copy of BioPharmX’s most recent SEC filings here.